RxP and BioTrove Ink SNP, Gene-Expression Deal | GenomeWeb

RxP and BioTrove Ink SNP, Gene-Expression Deal

Jan 30, 2006

NEW YORK, Jan. 30 (GenomeWeb News) - BioTrove and RxGen PrimaTox are working jointly to provide gene expression and SNP assays for primates and humans, BioTrove said today.

Under the deal, RxP will provide its tox-optimum assays exclusively to BioTrove, either as stand-alone products or as a service. BioTrove will manufacture the assays to RxP's specifications, using its OpenArray platform.

Financial details were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Spiders and Scorpions, Oh My!

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

Keep It Secret

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Page Joins Chronic Disease Startup

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

This Week in Cell

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.